Grown Rogue International (GRUSF) Depreciation & Amortization - Total (2009 - 2026)
Grown Rogue International (GRUSF) recorded quarterly Depreciation & Amortization - Total of $91162.0 in Q1 2026, down 100.0% quarter-over-quarter from $121.2 billion in Q3 2025.
Grown Rogue International (GRUSF) Depreciation & Amortization - Total (2009 - 2026) Analysis & Trends
Grown Rogue International's Depreciation & Amortization - Total history runs 13 years deep, the most recent figure standing at $91162.0 for Q1 2026.
- In Q1 2026, Depreciation & Amortization - Total changed N/A year-over-year to $91162.0; the TTM figure through Mar 2026 stood at $121.2 billion (up 116.65% YoY), while the FY2023 annual figure was $186415.0, changed N/A from the prior year.
- Depreciation & Amortization - Total was $91162.0 for Q1 2026 at Grown Rogue International, down from $121.2 billion in the prior quarter.
- In the past five years, Depreciation & Amortization - Total ranged from a high of $121.2 billion in Q3 2025 to a low of -$728.1 billion in Q4 2024.
- Historically, Depreciation & Amortization - Total has averaged -$50.6 billion across 5 years, with a median of $146371.5 in 2023.
- The sharpest annual moves came in 2023 and 2025: Depreciation & Amortization - Total tumbled 71.7% in 2023, then surged 63182652.76% in 2025.
- A 5-year view of Depreciation & Amortization - Total shows it stood at $239683.0 in 2022, then slumped by 38.82% to $146627.8 in 2023, then tumbled by 496559465.93% to -$728.1 billion in 2024, then surged by 116.65% to $121.2 billion in 2025, then plunged by 100.0% to $91162.0 in 2026.
- The last three Depreciation & Amortization - Total figures came in at $91162.0 (Q1 2026), $121.2 billion (Q3 2025), and -$728.1 billion (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Tot) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | - |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | - |
| 10 | Grown Rogue International | - | - | 3.96 Mn | 91,162.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 91,162.00 |
| Sep 30, 2025 | 121.23 Bn |
| Dec 31, 2024 | -728.09 Bn |
| Sep 30, 2024 | 191,876.73 |
| Jun 30, 2024 | 154,484.88 |
| Mar 31, 2024 | 255,052.00 |
| Oct 31, 2023 | 146,627.80 |
| Jul 31, 2023 | 146,115.14 |
| Apr 30, 2023 | 67,820.00 |
| Jan 31, 2023 | 115,639.00 |
| Apr 30, 2022 | 239,683.00 |
| Jan 31, 2022 | 52,010.00 |
| Apr 30, 2021 | 40,546.00 |
| Jan 31, 2021 | 124,381.00 |
| Oct 31, 2020 | -19,696.00 |
| Apr 30, 2020 | 26,229.00 |
| Jan 31, 2020 | 49,677.00 |
| Oct 31, 2019 | -417,187.00 |
| Jul 31, 2019 | 157,867.00 |
| Apr 30, 2019 | 163,801.00 |